| SCHRODER ISF LATIN AMERICAN A DIS GBP | RVI LATINOAMÉRICA | 34,19% | 23,97% | 24,11% | 44,10% |
| INVESCO JAPANESE EQUITY ADVANTAGE A CAP EUR (HEDGED) | RVI JAPÓN | 34,18% | 59,56% | 61,18% | 174,41% |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 34,18% | 7,50% | -34,66% | · |
| SANTANDER AM LATIN AMERICAN EQUITY OPPORTUNITIES IE CAP | RVI LATINOAMÉRICA | 34,18% | 31,99% | 55,38% | 64,75% |
| GOLDMAN SACHS GLOBAL FUTURE ECONOMIC SECURITY EQUITY PORTFOLIO R USD DIS | RVI GLOBAL | 34,17% | · | · | · |
| MAN JAPAN COREALPHA EQUITY I JPY | RVI JAPÓN | 34,17% | 67,46% | · | 185,75% |
| BGF LATIN AMERICAN D2 GBP | RVI LATINOAMÉRICA | 34,16% | 42,18% | 52,48% | 81,31% |
| BGF WORLD TECHNOLOGY A2 AUD (HEDGED) | TMT | 34,14% | 67,49% | 13,65% | · |
| NOMURA FUNDS IRELAND - ASIA EX JAPAN HIGH CONVICTION FUND I USD | RVI ASIA EX-JAPÓN | 34,14% | 42,20% | 8,66% | 159,61% |
| AMSELECT ROBECO GLOBAL EQUITY EMERGING PRIVILEGE CAP | RVI EMERGENTES | 34,12% | 53,70% | · | · |
| AMSELECT ROBECO GLOBAL EQUITY EMERGING I CAP | RVI EMERGENTES | 34,11% | 53,69% | · | · |
| CT (LUX) ASIAN EQUITY INCOME AE EUR | RVI ASIA EX-JAPÓN | 34,10% | 38,22% | 20,64% | 130,57% |
| INVESCO STOXX EUROPE 600 OPTIMISED UTILITIES UCITS ETF ACC | UTILITIES | 34,10% | 64,10% | 73,65% | 172,25% |
| NOMURA FUNDS IRELAND - ASIA EX JAPAN HIGH CONVICTION FUND I EUR | RVI ASIA EX-JAPÓN | 34,10% | 42,52% | 8,69% | · |
| FRANKLIN TECHNOLOGY A (ACC) EUR-H1 | TMT | 34,09% | 71,01% | 22,99% | · |
| JPM EMERGING MARKETS OPPORTUNITIES C (DIST) USD | RVI EMERGENTES | 34,09% | 35,67% | -0,32% | 93,40% |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 34,09% | 7,33% | -34,80% | · |
| LAZARD EMERGING MARKETS EQUITY A DIS EUR | RVI EMERGENTES | 34,09% | 59,19% | 42,85% | · |
| LO FUNDS - ASIA HIGH CONVICTION SYST. NAV HDG (EUR) N CAP | RVI ASIA EX-JAPÓN | 34,08% | 50,64% | -3,44% | · |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO IO (SNAP) JPY CAP | RVI EMERGENTES | 34,07% | 58,03% | 32,35% | · |
